796 / 1068
10
CORS-03 study
229 patients with
anal carcinoma
Macroscopic LN
involvement
n= 99
N2/3
(iliac/inguinal LN)
n= 32
EBRT boost
n=33
BCT boost
n=34
N1
(perirectal LN)
n= 67
EBRT boost
n=16
BCT boost
n=16
No LN involvement
n= 130
CORS-3 study
Laurence Moureau-Zabotto et al, IJROBP 2013
BCT boost is superior to EBRT boost for local control , without an
influence on OS
N1 status should not be a contraindication for a BCT boost technique